RayzeBio
is a California-based biopharmaceutical company that researches and develops radiopharmaceutical drugs for the treatment of cancer... Read moreRayzeBio
is a California-based biopharmaceutical company that researches and develops radiopharmaceutical drugs for the treatment of cancer... Read more
News
Jun 05, 2024
Endpoints News
RayzeBio: RayzeBio warned of potential isotope supply issues before BMS deal
Feb 27, 2024
Pharamceutical Technology
RayzeBio: Bristol Myers Squibb acquires RayzeBio for $4.1bn
Feb 23, 2024
MarketScreener
RayzeBio: Bristol Myers: successful takeover bid for RayzeBio
Feb 23, 2024
Nasdaq
RayzeBio: Bristol Myers Squibb: Approx. 86% Of RayzeBio Common Stock Validly Tendered As Of Expiration Time
Feb 12, 2024
BioSpace
RayzeBio: Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period
Jan 27, 2024
MarketScreener
RayzeBio: RAYZEBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB
Jan 25, 2024
BioPharma Dive
RayzeBio: RayzeBio drew other pharma interest before Bristol Myers deal
Jan 08, 2024
PR-Inside
Press Release: RayzeBio : STOCKHOLDER ALERT: Juan Monteverde Encourages the Shareholders of RYZB, ...
Jan 08, 2024
Global Legal Chronicle
RayzeBio: Bristol Myers Squibb's $4.1 Billion Acquisition of RayzeBio
Jan 02, 2024
Citybizlist
RayzeBio: Bristol Myers Squibb To Acquire RayzeBio
RayzeBio Competitors
1
2
3
4
5
6
7
8
9
10